NHS launches groundbreaking sickle cell gene therapy
By Lee Peart 31 January 2025
A groundbreaking gene editing treatment is being offered to patients with sickle cell disease from today.
Director of Children’s Social Care and Early Help
£104,337 – £115,105
Oldham, Greater Manchester£104,337 – £115,105
Assistant Director – People Commissioning & Business Support
£96,350 – £108,925
Bradford, West Yorkshire£96,350 – £108,925
Director of Children’s Social Care and Early Help
£104,337 – £115,105
Oldham, Greater Manchester£104,337 – £115,105
Assistant Director – People Commissioning & Business Support
£96,350 – £108,925
Bradford, West Yorkshire£96,350 – £108,925
©2024 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
